Analysis of the Failure to Reach the Standard of Vancomycin Blood Trough Concentration in Critically Ill Patients and Its Influencing Factors

被引:0
作者
Li, Pu [1 ]
Li, Lu [1 ]
Chen, Rui-Lin [2 ]
Wu, Tao [3 ]
机构
[1] Air Force Med Univ, Dept Anesthesiol, Affiliated Hosp 2, Xian 710032, Shaanxi, Peoples R China
[2] Shaanxi Prov Peoples Hosp, Dept Pulm & Crit Care Med, Xian 710068, Shaanxi, Peoples R China
[3] Air Force Med Univ, Dept Gen Surg, Affiliated Hosp 2, Xian 710032, Shaanxi, Peoples R China
关键词
critically ill patients; vancomycin; blood trough concentration; substandard; influencing factor; CLEARANCE;
D O I
10.23812/j.biol.regul.homeost.agents.20233702.69
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study analyzes the failure of vancomycin blood trough concentration in critically ill patients and the influencing factors to provide a theoretical basis for its rational application. Methods: The data of 45 critically ill patients with infections induced by vancomycin treatment were retrospectively collected. Patients with a vancomycin blood trough concentration of <10 mg/L were assigned into the substandard group (n = 18), and those with a vancomycin blood trough concentration of >= 10 mg/L were assigned into the standard group (n = 27). Data such as age, gender, underlying diseases, treatment methods, albumin, creatinine, and glomerular filtration rate were analyzed, then multivariate analysis was performed using binary logistic regression. Results: The age, drug blood trough concentration, peak concentration, and blood creatinine concentration were significantly lower in the substandard group than in the standard group (p < 0.05), and the epidermal growth factor receptor (eGFR) level was significantly higher than in the standard group (p < 0.001). The rate of renal replacement therapy (RRT) was higher in the standard group than in the substandard group (p = 0.031). The factors with statistical differences between the two groups (age, blood drug peak concentration, eGFR, treatment methods, and continuous RRT) were used as the independent variables (X). Whether the blood concentration of vancomycin reached the standard was used as the dependent variable (Y). Binary multivari-ate logistic regression analysis was conducted. The results show that serum creatinine (p = 0.037, OR (odds ratio) = 1.248) and eGFR (p = 0.026, OR = 0.913) were independent influencing factors of vancomycin. Conclusions: The failure rate of vancomycin trough concentration in critically ill patients is higher. Serum creatinine and eGFR are independent associated factors for the substandard rate of vancomycin trough concentration.
引用
收藏
页码:687 / 691
页数:5
相关论文
共 25 条
[1]   Clinical and Pharmacokinetic Outcomes of Peak-Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial [J].
Al-Sulaiti, Fatima Khalifa ;
Nader, Ahmed Mohamed ;
Saad, Mohamed Omar ;
Shaukat, Adila ;
Parakadavathu, Rakesh ;
Elzubair, Ahmed ;
Al-Badriyeh, Daoud ;
Elewa, Hazem ;
Awaisu, Ahmed .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (05) :639-652
[2]   Pharmacokinetic Assessment of Vancomycin Loading Dose in Critically Ill Patients [J].
Alvarez, Osvaldo ;
Cristian Plaza-Plaza, Jose ;
Ramirez, Manuel ;
Peralta, Alexis ;
Amador, Cristian A. ;
Amador, Roberto .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (08)
[3]   Optimizing the Clinical Use of Vancomycin [J].
Alvarez, Rocio ;
Lopez Cortes, Luis E. ;
Molina, Jose ;
Cisneros, Jose M. ;
Pachon, Jeronimo .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) :2601-2609
[4]   Review of vancomycin-induced renal toxicity: an update [J].
Bamgbola, Oluwatoyin .
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2016, 7 (03) :136-147
[5]   Predicting the dose of vancomycin in ICU patients receiving different types of RRT therapy: a model-based meta-analytic approach [J].
Claisse, Guillaume ;
Zufferey, Paul J. ;
Trone, Jane C. ;
Maillard, Nicolas ;
Delavenne, Xavier ;
Laporte, Silvy ;
Ollier, Edouard .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (06) :1215-1226
[6]   The antibiotic vancomycin induces complexation and aggregation of gastrointestinal and submaxillary mucins [J].
Dinu, Vlad ;
Lu, Yudong ;
Weston, Nicola ;
Lithgo, Ryan ;
Coupe, Hayley ;
Channell, Guy ;
Adams, Gary G. ;
Gomez, Amelia Torcello ;
Sabater, Carlos ;
Mackie, Alan ;
Parmenter, Christopher ;
Fisk, Ian ;
Phillips-Jones, Mary K. ;
Harding, Stephen E. .
SCIENTIFIC REPORTS, 2020, 10 (01)
[7]   The dosing and monitoring of vancomycin: what is the best way forward? [J].
Drennan, Philip G. ;
Begg, Evan J. ;
Gardiner, Sharon J. ;
Kirkpatrick, Carl M. J. ;
Chambers, Steve T. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 53 (04) :401-407
[8]   Using a Vancomycin PBPK Model in Special Populations to Elucidate Case-Based Clinical PK Observations [J].
Emoto, Chie ;
Johnson, Trevor N. ;
McPhail, Brooks T. ;
Vinks, Alexander A. ;
Fukuda, Tsuyoshi .
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2018, 7 (04) :237-250
[9]  
Expert Group on Clinical Application Dose of Vancomycin, 2011, CHIN J NEW DRUGS CLI, V30, P561
[10]   The Nephrotoxicity of Vancomycin [J].
Filippone, E. J. ;
Kraft, W. K. ;
Farber, J. L. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (03) :459-469